1. A Calcitonin-Negative Neuroendocrine Tumor Derived from Follicular Lesions of the Thyroid
- Author
-
Chang Ho Cho, June Sik Park, Chul Yun Park, Eui Dal Jung, Eon Ju Jeon, and Ga Young Kim
- Subjects
Calcitonin ,Pathology ,medicine.medical_specialty ,endocrine system ,endocrine system diseases ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Case Report ,Neuroendocrine tumors ,Follicular cell ,lcsh:Diseases of the endocrine glands. Clinical endocrinology ,Thyroid carcinoma ,Endocrinology ,Medicine ,Carcinoma, medullary ,lcsh:RC648-665 ,biology ,business.industry ,Thyroid ,medicine.disease ,medicine.anatomical_structure ,Medullary carcinoma ,Synaptophysin ,biology.protein ,Thyroglobulin ,business - Abstract
Neuroendocrine lesions of the thyroid are rare. The most common types are medullary thyroid carcinomas (MTCs) and C-cell hyperplasia. MTCs originate from thyroid parafollicular cells that secrete calcitonin which serves as a serum marker of MTCs. Here, the rare case of a calcitonin-negative neuroendocrine tumor (NET) derived from follicular lesions of the thyroid is described. A 34-year-old man presented at our hospital for the surgical management of an incidental thyroid nodule that was observed on an ultrasound sonography (USG) of the neck. Initially, USG-guided aspiration cytology was performed, and a MTC was suspected. The expressions of thyroglobulin and thyroid transcription factor-1, which are thyroid follicular cell markers, and synaptophysin and chromogranin A, which are neuroendocrine markers, was confirmed following surgical pathology. However, the staining of calcitonin, a marker of MTCs, was not observed. A nonmedullary NET of the thyroid is uncommon, and the distinction between calcitonin-negative NETs and MTCs of the thyroid may be important due to differences in their clinical courses and management.
- Published
- 2015